Preclinical dynamic 18F-FDG PET - tumor characterization and radiotherapy response assessment by kinetic compartment analysis
- PMID: 20831478
- DOI: 10.3109/0284186X.2010.498831
Preclinical dynamic 18F-FDG PET - tumor characterization and radiotherapy response assessment by kinetic compartment analysis
Abstract
Background: Non-invasive visualization of tumor biological and molecular processes of importance to diagnosis and treatment response is likely to be critical in individualized cancer therapy. Since conventional static (18)F-FDG PET with calculation of the semi-quantitative parameter standardized uptake value (SUV) may be subject to many sources of variability, we here present an approach of quantifying the (18)F-FDG uptake by analytic two-tissue compartment modeling, extracting kinetic tumor parameters from dynamic (18)F-FDG PET. Further, we evaluate the potential of such parameters in radiotherapy response assessment.
Material and methods: Male, athymic mice with prostate carcinoma xenografts were subjected to dynamic PET either untreated (n=8) or 24 h post-irradiation (7.5 Gy single dose, n=8). After 10 h of fasting, intravenous bolus injections of 10-15 MBq (18)F-FDG were administered and a 1 h dynamic PET scan was performed. 4D emission data were reconstructed using OSEM-MAP, before remote post-processing. Individual arterial input functions were extracted from the image series. Subsequently, tumor (18)F-FDG uptake was fitted voxel-by-voxel to a compartment model, producing kinetic parameter maps.
Results: The kinetic model separated the (18)F-FDG uptake into free and bound tracer and quantified three parameters; forward tracer diffusion (k(1)), backward tracer diffusion (k(2)), and rate of (18)F-FDG phosphorylation, i.e. the glucose metabolism (k(3)). The fitted kinetic model gave a goodness of fit (r(2)) to the observed data ranging from 0.91 to 0.99, and produced parametrical images of all tumors included in the study. Untreated tumors showed homogeneous intra-group median values of all three parameters (k(1), k(2) and k(3)), whereas the parameters significantly increased in the tumors irradiated 24 h prior to (18)F-FDG PET.
Conclusions: This study demonstrates the feasibility of a two-tissue compartment kinetic analysis of dynamic (18)F-FDG PET images. If validated, extracted parametrical maps might contribute to tumor biological characterization and radiotherapy response assessment.
Similar articles
-
Quantitative studies using positron emission tomography (PET) for the diagnosis and therapy planning of oncological patients.Hell J Nucl Med. 2006 Jan-Apr;9(1):10-21. Hell J Nucl Med. 2006. PMID: 16617388
-
(18)F-alfatide II and (18)F-FDG dual-tracer dynamic PET for parametric, early prediction of tumor response to therapy.J Nucl Med. 2014 Jan;55(1):154-60. doi: 10.2967/jnumed.113.122069. Epub 2013 Nov 14. J Nucl Med. 2014. PMID: 24232871 Free PMC article.
-
111In-cetuximab-F(ab')2 SPECT and 18F-FDG PET for prediction and response monitoring of combined-modality treatment of human head and neck carcinomas in a mouse model.J Nucl Med. 2015 Feb;56(2):287-92. doi: 10.2967/jnumed.114.148296. Epub 2014 Dec 31. J Nucl Med. 2015. PMID: 25552666
-
Strategies of assessing and quantifying radiation treatment metabolic tumor response using F18 FDG Positron Emission Tomography (PET).Acta Oncol. 2010 Oct;49(7):948-55. doi: 10.3109/0284186X.2010.510533. Acta Oncol. 2010. PMID: 20831482 Review.
-
Quantitative assessment of tumor metabolism using FDG-PET imaging.Nucl Med Biol. 2000 Oct;27(7):683-7. doi: 10.1016/s0969-8051(00)00141-4. Nucl Med Biol. 2000. PMID: 11091112 Review.
Cited by
-
The role of endoplasmic reticulum in in vivo cancer FDG kinetics.PLoS One. 2021 Jun 1;16(6):e0252422. doi: 10.1371/journal.pone.0252422. eCollection 2021. PLoS One. 2021. PMID: 34061902 Free PMC article.
-
Augmentation of [18F]-C-SNAT4 PET imaging of apoptosis after radiotherapy using a cold mixing strategy.EJNMMI Res. 2025 Jun 3;15(1):65. doi: 10.1186/s13550-025-01255-1. EJNMMI Res. 2025. PMID: 40459707 Free PMC article.
-
Dynamic profiles of early biological responses to predict the treatment efficacy of proton therapy in liver cancer assessed with in vivo kinetic [18F]-FDG PET/MRI.Radiat Oncol. 2025 Jun 6;20(1):96. doi: 10.1186/s13014-025-02673-0. Radiat Oncol. 2025. PMID: 40481463 Free PMC article.
-
Targeting presynaptic norepinephrine transporter in brown adipose tissue: a novel imaging approach and potential treatment for diabetes and obesity.Synapse. 2013 Feb;67(2):79-93. doi: 10.1002/syn.21617. Epub 2012 Nov 8. Synapse. 2013. PMID: 23080264 Free PMC article.
-
Influx rate of 18F-fluoroaminosuberic acid reflects cystine/glutamate antiporter expression in tumour xenografts.Eur J Nucl Med Mol Imaging. 2019 Sep;46(10):2190-2198. doi: 10.1007/s00259-019-04375-8. Epub 2019 Jul 1. Eur J Nucl Med Mol Imaging. 2019. PMID: 31264167
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources